SCHEMBL8539719

SCHEMBL8539719

CCOC(=O)COc1ccc(OCC2CO2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.56
NPSR1 Q6W5P4 1/20 0.56
POLB P06746 2/20 0.52
ALDH1A1 P00352 6/20 0.51
MAPT P10636 5/20 0.51
HPGD P15428 4/20 0.51
TP53 P04637 3/20 0.51
TSHR P16473 2/20 0.51
PKM P14618 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
LMNA P02545 2/20 0.51
CYP1A2 P05177 1/20 0.51
PPARG P37231 1/20 0.51
HIF1A Q16665 1/20 0.51
KDM4E B2RXH2 4/20 0.50
HSD17B10 Q99714 3/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALOX15 P16050 1/20 0.48
EPHX2 P34913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8537967 0.86 MGLL (0.56) GAAALDH1A1MAPTHPGDTP53
SCHEMBL8537272 0.83 CYP4F2 (0.55) GAAALDH1A1MAPTHPGDTP53
SCHEMBL8536518 0.82 ALDH1A1 (0.51) GAAALDH1A1MAPTHPGDTP53
SCHEMBL11023146 0.81 MGLL (0.59) GAAALDH1A1MAPTHPGDTP53
SCHEMBL12567737 0.81 ALDH1A1 (0.52) GAAALDH1A1MAPTHPGDTP53
SCHEMBL1462460 0.79 TSHR (0.66) GAAALDH1A1MAPTHPGDTP53
SCHEMBL7694888 0.79 TSHR (0.66) GAAALDH1A1MAPTHPGDTP53
SCHEMBL11815554 0.79 GAA (0.72) GAANPSR1POLBALDH1A1MAPT
SCHEMBL10692831 0.79 ALDH1A1 (0.54) GAAALDH1A1MAPTHPGDTP53
SCHEMBL10692834 0.79 ALDH1A1 (0.54) GAAALDH1A1MAPTHPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0485045-B1 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them SCHERING AG (DE) 1998-12-30 EP disclosed
US-5277895-A Nuclear magnetic resonance SCHERING AKTIENGESELLSCHAFT (DE) 1994-01-11 US disclosed
EP-0485045-A2 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them SCHERING AKTIENGESELLSCHAFT (DE) 1992-05-13 EP disclosed